Mantoani SP

References (3)

Title : Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease - de Andrade_2019_Bioorg.Med.Chem_27_931
Author(s) : de Andrade P , Mantoani SP , Goncalves Nunes PS , Magadan CR , Perez C , Xavier DJ , Hojo ETS , Campillo NE , Martinez A , Carvalho I
Ref : Bioorganic & Medicinal Chemistry , 27 :931 , 2019
Abstract :
PubMedSearch : de Andrade_2019_Bioorg.Med.Chem_27_931
PubMedID: 30765302

Title : From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease - Chierrito_2017_Eur.J.Med.Chem_139_773
Author(s) : Chierrito TPC , Mantoani SP , Roca C , Requena C , Sebastian-Perez V , Castillo WO , Moreira NCS , Perez C , Sakamoto-Hojo ET , Takahashi CS , Jimenez-Barbero J , Canada FJ , Campillo NE , Martinez A , Carvalho I
Ref : Eur Journal of Medicinal Chemistry , 139 :773 , 2017
Abstract :
PubMedSearch : Chierrito_2017_Eur.J.Med.Chem_139_773
PubMedID: 28863358

Title : Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors - Mantoani_2016_Molecules_21_
Author(s) : Mantoani SP , Chierrito TP , Vilela AF , Cardoso CL , Martinez A , Carvalho I
Ref : Molecules , 21 : , 2016
Abstract :
PubMedSearch : Mantoani_2016_Molecules_21_
PubMedID: 26861273